Primus In News
Multinational pharma cos, Indian drugmakers diverge to mutual gain
11-03-2026
Vivek Tandon, Vice President, Primus Partners, shared that multinational corporations are experiencing financial pressure. "This change has less to do with financial strain and more to do with strategic alignment. Legacy brands may still generate cash, but they don’t fit an innovation-led, globally scalable model.
Explore Related Insights
- Incentives for green hydrogen likely in Union Budget
- India's considering aircraft boneyards for retired jets-and for cheaper parking
- Budget 2026: Big Announcements, But Effective Implementation Is Real Test
- DPIIT’s framework for AI copyright faces questions on transparency, consent, and compliance costs
